PRNewsWire
28 May 2026, 10:45 UTC · 2h ago
Source · https://www.prnewswire.com/news-releases/foundayo-and-zepbound-now-covered-for-millions-of-americans-302784360.html
Read source
Search tags
Story key points
3 claims · impact-rated
All three of the largest U.S. pharmacy benefit managers (PBMs) will now cover Eli Lilly's full obesity medicine portfolio, including Zepbound and Foundayo. — Broad insurance coverage across the dominant PBMs drastically removes a primary barrier to patient access, likely leading to a significant surge in prescription volume and revenue for LLY.
+0.80CVS Caremark will begin covering Foundayo on June 1 and will resume Zepbound coverage by October 1. — Specific timelines for coverage from one of the largest PBMs provide a concrete catalyst for short-term revenue growth.
+0.60Medicare Part D beneficiaries may be eligible to pay $50 per month for obesity medicines starting July 1 through the Medicare GLP-1 Bridge program. — Expanding access to the elderly demographic via Medicare opens a massive new patient pipeline and reduces out-of-pocket costs.
+0.50Ticker attribution
Model heads
The company announced a major access milestone with all three largest PBMs covering its full obesity medicine portfolio.
CVS Caremark is mentioned as a PBM providing coverage, which is a standard operational function.
Impact vectors
10 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
